NMPA Approves Zynlonta for Relapsed or Refractory Large B-Cell Lymphoma Treatment
The website of China’s National Medical Products Administration (NMPA) has indicated that the marketing filing...
The website of China’s National Medical Products Administration (NMPA) has indicated that the marketing filing...
China-based Wuhan YZY Biopharma Co., Ltd (HKG: 2496) has announced the presentation of results from...
China-based Contract Development and Manufacturing Organization (CDMO) Porton Pharma Solutions (SHE: 300363) has announced a...
US-based Stereotaxis, Inc. (NYSEAMERICAN: STXS) and its Chinese partner Shanghai MicroPort EP Medtech Co., Ltd....
Immunofoco, a leading developer in tumor immunotherapy based in Suzhou, has announced that it has...
Beijing-based gene therapy specialist InnoVec Biotherapeutics Inc. has announced receiving Investigational New Drug (IND) approval...
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Ltd (HKG: 2142), has joined forces with...
Eisai’s (TYO: 4523) China unit has announced that it has received marketing approval from the...
Partners Daiichi Sankyo (TYO: 4568) and AstraZeneca (AZ, NASDAQ: AZN) have jointly announced that their...
Shanghai Pharmaceuticals (SHA: 601607; SPH) has entered into a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical...
China Medical System Holdings (CMS; HKG: 0867) has announced that the first prescriptions have been...
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) has presented new data from a pooled safety...
US-based pharmaceutical company AbbVie (NYSE: ABBV) has revealed positive top-line results from the pivotal Phase...
US pharmaceutical major Eli Lilly and Company (NYSE: LLY) unveiled the latest data from the...
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has confirmed reports regarding its intention to make...
China-based Keymed Biosciences Inc., (HKG: 2162) has announced the presentation of the latest data from...
China-based Antengene Corporation Limited (Antengene, HKG: 6996) announced the presentation of the latest results from...
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has announced...
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced that the National Medical Products...
UK-based pharmaceutical giant GSK (NYSE: GSK) has announced that the US Food and Drug Administration...